This online shop is using cookies to give you the best shopping experience. Thereby for example the session information or language setting are stored on your computer. Without cookies the range of the online shop's functionality is limited.
If you do not agree, please click here.
Today we turn to you with news: Our new webshop is online!
Our customers benefit from a contemporary system that improves the comfort in the application. In addition to many updates and improvements the shop is now optimized for all digital devices (cellphones, tablets etc.).
Information for customers who already have an account
To continue logging in with your old account, you must reset or re-enter your password once. In this case please use the link “Forgotten password?”.
Since the publication of the third series of the Armed Forces Institute of Pathology (AFIP) Fascicle on Tumors of the Esophagus and Stomach, great advances in many areas of tumor biology have led to a better understanding of the pathogenesis, pathology, and molecular biology of epithelial and stromal malignancies of the upper gastrointestinal tract.
Notable advances described in this publication include:
expansion of our understanding of the pathologic features and molecular pathogenesis of carcinomas of the esophagus and stomach, most of which develop through a chronic inflammation-metaplasia-dysplasia-carcinoma sequence
discovery of new diseases, such as gastric adenocarcinoma and proximal polyposis syndrome (GAPPS), a special variant of familial adenomatous polyposis, and significant advances in our knowledge regarding the molecular characterization of genetic polyposis syndromes
great expansion in the molecular-pathology correlation, morphologic diversity, classification, and therapeutic options of gastrointestinal stromal tumors (GISTs)
reclassification and refinement of prognostic factors related to neuroendocrine tumors
improvements in the role of cytology in the diagnosis of tumors of the upper gastrointestinal tract
This edition of the Fascicle was written to help pathologists diagnose diseases more accurately and understand how pathology contributes to clinical treatment in the new age of personalized and targeted therapy.
LESS DISCOUNT FOR SUBSCRIBERS OF THE COMPLETE SERIES (UNWANTED VOLUMES MAY BE RETURNED WITHIN FOUR WEEKS)